cdmo.directory
← Compare landing

Cell and Gene Therapy Catapult vs Mytos Inc.

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryCell and Gene Therapy CatapultMytos Inc.
SummaryUK-based innovation and manufacturing support organization for cell and gene therapies, offering infrastructure, expertise, and collaboration across the ATMP lifecycle.Mytos is an automated CDMO for regenerative medicines, using its iDEM platform to produce stem-cell derived therapies. The company says its automation lets clients scale in months rather than years at lower cost per batch.
Services
  • Cell-Line Development
  • Upstream Processing
  • Downstream Processing
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Process Development
  • Technology Transfer
  • CMC Analytical Development
  • CMC Regulatory Submission Support
  • Cell Therapy Manufacturing
Modalities
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
  • Cell Therapy
Development capabilities
  • Analytical method development
  • Formulation development
  • Cell line development
Data not yet provided.
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Expression: Mammalian
  • Expression: Viral Vector
  • Single-Use / Disposable
Data not yet provided.
Locations
  • Headquarters, Stevenage, Hertfordshire, United Kingdom
  • London, London, England, United Kingdom
  • Braintree, Braintree, Essex, United Kingdom
  • Edinburgh, Edinburgh, Scotland, United Kingdom
  • Headquarters, United Kingdom
  • UK facility, United Kingdom
  • London, London, England, United Kingdom
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Cell and Gene Therapy Catapult alternatives · Mytos Inc. alternatives

Markdown mirror: /compare/ct/mytos.md